Cabio Biotech Wuhan Co Ltd (688089) — Tangible Net Worth Ratio
Cabio Biotech Wuhan Co Ltd (688089) has a Tangible Net Worth Ratio of 97.4% as of September 2025. This metric is calculated by deducting intangible assets (CN¥41.88 Million) from net assets (CN¥1.64 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Cabio Biotech Wuhan Co Ltd book value and equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Cabio Biotech Wuhan Co Ltd Tangible Net Worth Ratio (2013–2024)
This chart shows how Cabio Biotech Wuhan Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 97.4%, reflecting net assets of CN¥1.64 Billion with intangible assets of CN¥41.88 Million CNY. Also explore net asset growth rate of Cabio Biotech Wuhan Co Ltd to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Cabio Biotech Wuhan Co Ltd (2013–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Cabio Biotech Wuhan Co Ltd from 2013 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Cabio Biotech Wuhan Co Ltd worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.3% | CN¥1.57 Billion | CN¥43.09 Million | CN¥1.69 Billion | ▲ +0.0 pp |
| 2023 | 97.2% | CN¥1.49 Billion | CN¥41.08 Million | CN¥1.61 Billion | ▼ -0.2 pp |
| 2022 | 97.5% | CN¥1.43 Billion | CN¥36.34 Million | CN¥1.61 Billion | ▼ -1.6 pp |
| 2021 | 99.0% | CN¥1.38 Billion | CN¥13.15 Million | CN¥1.45 Billion | ▲ +0.1 pp |
| 2020 | 98.9% | CN¥1.32 Billion | CN¥14.54 Million | CN¥1.38 Billion | ▲ +0.0 pp |
| 2019 | 98.9% | CN¥1.25 Billion | CN¥14.30 Million | CN¥1.30 Billion | ▲ +3.4 pp |
| 2018 | 95.5% | CN¥526.20 Million | CN¥23.86 Million | CN¥581.19 Million | ▲ +0.9 pp |
| 2017 | 94.6% | CN¥464.39 Million | CN¥25.21 Million | CN¥506.37 Million | ▲ +1.2 pp |
| 2016 | 93.4% | CN¥402.60 Million | CN¥26.51 Million | CN¥476.78 Million | ▼ -1.6 pp |
| 2015 | 95.0% | CN¥354.83 Million | CN¥17.66 Million | CN¥440.43 Million | ▼ -1.0 pp |
| 2014 | 96.0% | CN¥465.90 Million | CN¥18.60 Million | CN¥507.41 Million | ▲ +1.6 pp |
| 2013 | 94.4% | CN¥428.24 Million | CN¥23.89 Million | CN¥467.92 Million | — |